Martoma Trial Pushed Back To January

Sep 25 2013 | 12:15pm ET

Former SAC Capital Management portfolio manager Mathew Martoma won't face a jury until next year, a judge has ruled.

U.S. District Judge Paul Gardephe postponed Martoma's trial on insider-trading charges until Jan. 6. The delay was requested by Martoma's lawyer, Richard Strassberg, who is part of the team defending Bank of America against federal mortgage-fraud allegations. That trial began this week.

Martoma is accused of trading on confidential information about pharmaceutical trials, earning or saving SAC some $276 million. His trial was scheduled to start on Nov. 4.

As if to emphasize the need for a delay, Strassberg arrived to the hearing an hour late, out of breath. When Gardephe took the bench, Strassberg said that the judge in the BofA case had ordered him to return just a half-hour later.

Strassberg told Gardephe, "I personally appreciate this," and then asked the judge to push the trial back by a further week, a request that was not opposed by prosecutors. Gardephe said he'd consider it if his schedule allowed.

"I have my own trial calendar," Gardephe said.

The judge also froze Martoma's Boca Raton, Fla., home and more than $4 million in accounts held by himself and his wife. Prosecutors said they'd go after the assets if Martoma were convicted.


In Depth

Q&A: Star Mountain's Brett Hickey On Investing In 'The Growth Engine Of America'

Sep 22 2017 | 5:06pm ET

Lower middle-market companies form the economic fabric of the nation, but they can...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Don’t Overlook These 6 Hybrid Cloud Concerns

Sep 14 2017 | 6:27pm ET

Cloud-based technology solutions have made tremendous inroads into the alternative...

 

From the current issue of

Business Insider has been reporting on the unusual trading activity of a mystery trader who placed a profitable short equity bet to the tune of $21 million on the Aug. 10 move in the CBOE Volatility Index (VIX).